Although mostly studied for its involvement in Alzheimer’s disease, SorLA has recently been shown to be implicated in immune response by regulating IL-6-mediated signaling, as well as driving monocyte migration. Here, IL6 is linked to early-onset autosomal dominant Alzheimer disease.